LANGEPHARM ApS: Financial statements 2020
CVR: 25198956
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
LANGEPHARM ApS (CVR 25198956) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -32,976 and a net result of DKK -25,721 compared with DKK 161,588 the year before. Equity in the 2020 report amounted to DKK 839,021. The solvency ratio was 89.4%.
- Gross Profit
- DKK -32,976
- Profit/Loss
- DKK -25,721
- Equity
- DKK 839,021
- Total Assets
- DKK 938,161
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -33 t. | -26 t. | 839 t. | - |
| 2019 | - | 184 t. | 162 t. | 1.1 mio. | 0 |
| 2018 | - | 205 t. | 89 t. | 941 t. | 1 |
| 2017 | - | 197 t. | 104 t. | 852 t. | 1 |
| 2016 | - | 129 t. | 115 t. | 748 t. | - |
Official annual report
How creditworthy is LANGEPHARM ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
LANGEPHARM ApS has published its annual report for 2019. Gross profit came to DKK 184,031, and the net result was DKK 161,588.
About LANGEPHARM ApS
LANGEPHARM ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company has been dissolved on 29 March 2023. The company was registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named SKIN CARE CONSULTING ApS. The company has 0 employees (2018). In 2022, the company reported a gross profit of DKK -8,468 and a net result of DKK -6,610 compared with DKK -9,353 the year before. Equity in the 2022 report amounted to DKK 823,059.